跳至主要内容
临床试验/TCTR20181002002
TCTR20181002002已完成3 期

SertraLine Administration to prevent inTrAdialytic hypotensioN:A randomized, double-blinded, placebo-controlled, crossover study

Renal Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University0 个研究点目标入组 40 人开始时间: 2018年10月2日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age of 18 years old or older
  • 2. End-stage renal disease (ESRD) patients (defined by Kidney Disease Initiative Global Outcome (KDIGO) Guideline 2012) requiring chronic hemodialysis
  • 3. Hemodialysis vintage of more than 3 months
  • 4. Hemodialysis with 3 sessions per week
  • 5. History of intradialytic hypotension in at least 25% of their dialysis sessions during the past 2 months

排除标准

  • 1. Active cardiac disease
  • 2. Sepsis or septic shock
  • 3. Require ultrafiltration of more than 3.5 L per session
  • 4. Active malignancy
  • 5. Prior treatment with Selective serotonin reuptake inhibitors (SSRIs) in the past 4 weeks

研究者

发起方
Renal Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University

相似试验